Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium.
about
Cystatin C: a candidate biomarker for amyotrophic lateral sclerosisPrognosis of ALS: comparing data from the Limousin referral centre, France, and a Uruguayan population.Use of volume-targeted non-invasive bilevel positive airway pressure ventilation in a patient with amyotrophic lateral sclerosisHome mechanical ventilation in South Korea.Using respiratory rate and thoracic movement to assess respiratory insufficiency in amyotrophic lateral sclerosis: a preliminary study.Pulmonary function tests in patients with amyotrophic lateral sclerosis and the association between these tests and survivalPatterns of mortality in patients with motor neurone disease.Mechanical insufflation-exsufflation: Practice patterns among respiratory therapists in Ontario.Prognosis of amyotrophic lateral sclerosis with respiratory onset.Prognostic factors in ALS: A critical reviewState and metropolitan area-based amyotrophic lateral sclerosis (ALS) surveillance.Clinical trials in ALS: what did we learn from recent trials in humans?Prospective study of chemical exposures and amyotrophic lateral sclerosis.Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis.What makes a prognostic biomarker in CNS diseases: strategies for targeted biomarker discovery? Part 2: chronic progressive and relapsing disease.Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection.Disease progression and survival in ALS: first multi-state model approach.The effects of sa-am acupuncture treatment on respiratory physiology parameters in amyotrophic lateral sclerosis patients: a pilot study.Amyotrophic lateral sclerosis: prognostic indicators of survival.Updated Prevalence and Demographic Characteristics for ALS Cases in Texas, 2009-2011.Disease progression in amyotrophic lateral sclerosis: predictors of survival.Prognostic categories for amyotrophic lateral sclerosis.The use of non-invasive ventilation at end of life in patients with motor neurone disease: a qualitative exploration of family carer and health professional experiences.Longitudinal modeling to predict vital capacity in amyotrophic lateral sclerosis.Diaphragm pacing improves sleep in patients with amyotrophic lateral sclerosis.A role for functional classification in the early identification of prognostic factors in ALS.Modifying effect of arterial hypertension on amyotrophic lateral sclerosisLong-term survival in a patient with amyotrophic lateral sclerosis and respiratory presentationSurvival
P2860
Q28476466-75DAE200-3CED-483C-9F85-E0D620E1BFE9Q33516152-2C7DB458-B5B2-4503-B8F1-2E5C0BA47907Q34360255-3229C8CE-1032-425E-8123-0C3E1F1337AEQ34384496-8F656E24-C18C-4881-86E2-294A94A6012EQ34523766-8FD4843B-833C-4856-AA1D-A8DC053686E7Q34558955-48C9B764-4A19-4608-A4F0-7BE9E48189B6Q35050938-19C90C70-41E2-4D6B-A574-292785489B6CQ35742650-86A8C8FC-78C3-4B21-8D25-2067428785ABQ36143806-BBB9247D-BC34-4F93-8C08-987D3D1E405CQ36447824-3F9C1F2D-94EC-4AB5-9C8F-996CADFF81A6Q36518995-8DC52348-5580-4E07-9892-8FF220DB12D6Q36565680-69C0AEFA-E17E-492F-A50B-DE990467685FQ37395443-5C3C75E1-43B4-4D3F-BD94-79C1AAF444ECQ37683640-13F41C94-48C9-486F-BD6A-58FEE9F6560FQ38088747-1995707E-58A7-4908-BDF3-740C105816A0Q38847200-CE5ADE27-1DD5-4F15-A2AE-32FCEDD1471FQ39023321-E25A13FF-B646-424E-9829-1ABFDE48D483Q39337820-8C89D255-E5E2-46D6-88EF-B2749E68A7C7Q40266440-194EA3B1-EE5C-4116-81C8-129FF0709DC0Q40635721-F9DFDF57-2804-4F22-BE9D-C9C2052AB3AFQ40642209-5B82A88E-65FA-481D-8EF4-BC700F9884D7Q43432691-524FF705-7AA6-4109-A4C2-01AB5AF5A813Q46360581-BB8F05FD-DE3B-4D3C-A61B-F19D2D5755C8Q47675949-7E639929-DD29-4063-A01F-92B3CE1E2E75Q48277253-642D97F5-968E-4B33-9E87-3D40B540EE02Q53566307-B3619200-1AAB-479C-9CD3-0EE670905477Q57605693-8EAFA860-F66E-4FCF-8E08-7FD504BA5F57Q58125533-543C1590-2C00-474B-9D41-402FA5D5E51DQ58147398-AD19816C-2150-42BD-8D0D-D6C6DC14D9AF
P2860
Amyotrophic lateral sclerosis: mortality risk during the course of the disease and prognostic factors. The Netherlands ALS Consortium.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh-hant
name
Amyotrophic lateral sclerosis: ...... he Netherlands ALS Consortium.
@en
Amyotrophic lateral sclerosis: ...... he Netherlands ALS Consortium.
@nl
type
label
Amyotrophic lateral sclerosis: ...... he Netherlands ALS Consortium.
@en
Amyotrophic lateral sclerosis: ...... he Netherlands ALS Consortium.
@nl
prefLabel
Amyotrophic lateral sclerosis: ...... he Netherlands ALS Consortium.
@en
Amyotrophic lateral sclerosis: ...... he Netherlands ALS Consortium.
@nl
P2093
P1476
Amyotrophic lateral sclerosis: ...... he Netherlands ALS Consortium.
@en
P2093
C E Visser
E S Louwerse
G J Weverling
P M Bossuyt
P356
10.1016/S0022-510X(97)00238-4
P478
152 Suppl 1
P577
1997-10-01T00:00:00Z